Rights and permissions
About this article
Cite this article
Anticoagulant activity should be monitored after starting or changing celecoxib therapy in patients receiving warfarin. React. Wkly. 754, 3 (1999). https://doi.org/10.2165/00128415-199907540-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199907540-00005